Abstract | BACKGROUND: PATIENTS AND METHODS: RESULTS: Our analyses demonstrate an epithelial downregulation of CEACAM1 in superficial bladder tumors and in PIN of the prostate. Concurrently, CEACAM1 is upregulated in endothelial cells of tumor blood vessels. CEACAM1 knockdown in tumor cell lines of the prostate and urinary bladder via siRNA results in an increase of tumor vascularization while CEACAM1 overexpression in these cells suppresses it. CONCLUSIONS: CEACAM1-induced signaling mechanisms play a role in induction of angiogenesis in superficial tumors of the prostate and bladder. Strategies to either conserve the epithelial CEACAM1 or to target endothelial CEACAM1 might be useful for an antiangiogenic therapy of bladder and prostate cancer.
|
Authors | D Tilki, L Oliveira-Ferrer, N Kilic, M G Friedrich, C G Stief, S Ergun |
Journal | Der Urologe. Ausg. A
(Urologe A)
Vol. 46
Issue 9
Pg. 1128-34
(Sep 2007)
ISSN: 0340-2592 [Print] Germany |
Vernacular Title | Ein Molekül, zwei Gesichter. Epithelialer Verlust des Zelladhäsionsmoleküls CEACAM1 aktiviert Angiogenese beim Harnblasen- und Prostatakarzinom. |
PMID | 17605118
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antigens, CD
- CD66 antigens
- Cell Adhesion Molecules
|
Topics |
- Antigens, CD
(genetics)
- Blotting, Western
- Carcinoma, Transitional Cell
(blood supply, genetics, pathology)
- Cell Adhesion Molecules
(genetics)
- Cell Line, Tumor
- Epithelium
(blood supply, pathology)
- Female
- Gene Expression Regulation, Neoplastic
(genetics)
- Humans
- Male
- Microscopy, Electron
- Neoplasm Invasiveness
(genetics, pathology)
- Neoplasm Staging
- Neovascularization, Pathologic
(genetics, pathology)
- Prostate
(blood supply, pathology)
- Prostatic Neoplasms
(blood supply, genetics, pathology)
- Reverse Transcriptase Polymerase Chain Reaction
- Urinary Bladder
(blood supply, pathology)
- Urinary Bladder Neoplasms
(blood supply, genetics, pathology)
|